EVT 075
Alternative Names: EVT-075Latest Information Update: 16 Mar 2022
At a glance
- Originator Sanofi
- Class Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections; Hepatitis B
Most Recent Events
- 20 Jan 2022 Preclinical trials in COVID-2019 infections in Germany (unspecified route) (Evotec SE pipeline, January 2022)
- 20 Jan 2022 Preclinical trials in Hepatitis B in Germany (unspecified route) (Evotec SE pipeline, January 2022)
- 20 Jan 2022 Evotec SE plans a phase I trial for COVID-2019 infections by 2023 (Evotec SE website, January 2022)